Genprex GNPX
NASDAQ GNPX
$2.63 +0.07 (+2.73%)
At close: Oct 2, 2026 · 4:00 PM EDT

Genprex (GNPX) Return on Capital Employed [ROCE] (2017 - 2025)

Updated

Genprex's Return on Capital Employed [ROCE] was -593.72% in Q1 2025, down 237.89 percentage points from -355.83% a year earlier but up 807.04 percentage points from the prior quarter.

Analysis

Genprex (GNPX) Return on Capital Employed [ROCE] (2017 - 2025) Analysis & Trends

For FY2024, Return on Capital Employed [ROCE] at Genprex came in at -432.72%, down 220.34 percentage points from FY2023.

  • Return on Capital Employed [ROCE] has now declined for three consecutive years, with a five-year change of -251.38 percentage points (FY2019 to FY2024).
  • In earlier years, Return on Capital Employed [ROCE] was -212.38% in FY2023 (-135.90 pp), -76.47% in FY2022 (-18.29 pp), -58.18% in FY2021 (+47.48 pp) and -105.66% in FY2020 (+75.69 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -1400.76% (Q4 2024) and -35.43% (Q2 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has declined for 13 straight quarters, with an average year-over-year change of -341.04 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q4 2020 (a gain of 257.89 percentage points); the worst was Q4 2024 (a drop of 1102.21 percentage points).
  • Per Business Quant data, GNPX's Return on Capital Employed [ROCE] in the three quarters before Q1 2025 was -1400.76% (Q4 2024), -756.75% (Q3 2024) and -358.60% (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Genprex 1.33 Mn -40.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -593.72%
Dec 31, 2024 -1,400.76%
Sep 30, 2024 -756.75%
Jun 30, 2024 -358.60%
Mar 31, 2024 -355.83%
Dec 31, 2023 -298.54%
Sep 30, 2023 -265.24%
Jun 30, 2023 -190.74%
Mar 31, 2023 -143.46%
Dec 31, 2022 -96.46%
Sep 30, 2022 -80.55%
Jun 30, 2022 -61.07%
Mar 31, 2022 -50.29%
Dec 31, 2021 -45.31%
Sep 30, 2021 -38.75%
Jun 30, 2021 -35.43%
Mar 31, 2021 -43.60%
Dec 31, 2020 -66.75%
Sep 30, 2020 -64.03%
Jun 30, 2020 -60.37%
API Access

Genprex Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GNPX&period=max&api_key=YOUR_API_KEY